Benzodiazepine spirohydantoin CGRP receptor antagonists

Details for Australian Patent Application No. 2004226018 (hide)

International Classifications

Event Publications

1 September 2005 PCT application entered the National Phase

PCT publication WO2004/087649 Priority application(s): WO2004/087649

13 August 2009 Amendment Made

The nature of the amendment is: Amend the invention title to read Benzodiazepine spirohydantoin CGRP receptor antagonists

27 August 2009 Application Accepted

Published as AU-B-2004226018

24 December 2009 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend the Patentee from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.